www.biospectrumasia.com - March 12, 2008

Bangalore, March 12, 2008: Marck Biosciences Ltd, a Mumbai based manufacturer of sterile liquid parenterals and blow Fill Seal has entered the Latin American market.

Marck said today that it has received ANVISA approval for sterile injectibles exports to Brazil. Marck will roll out its Latin American foray beginning with Brazil. Argentina, Chile, Columbia, Mexico, Peru & Venezuela are the other Latin American market Marck will target.

"Marck is the only Indian manufacturer to have its facilities ANVISA approved for Sterile Injectables including Lignocaine, Salts, Normal Saline and Water for Injections in Blow Fill Seal segment. We seek to capture major share by direct export initiatives & business outsourcing options," says Mr. Bhavesh Patel, Managing Director, Marck Biosciences.

Brazil's large market for dry powder injections and oncology injectibles provides strong opportunities to Marck, forging alliance with Brazilian Pharma majors in diluents segment. Brazil's Small Volume Parenterals market constitutes 2/3rd of entire sterile formulations market that stands at $10million.

Marck has one of the largest installations of its kind in Asia with equally sizable capacity in LVP space.  "With the ANVISA approval and the large SVP capacity, we are now uniquely positioned to be the outsourcing partners of choice to all the well established pharmaceuticals companies of Brazil and other Latin American countries. This would be in addition to our own product portfolio, " adds Patel. © BioSpectrum Bureau.